Nath Bio-Genes (India) Limited (NATHBIOGEN)

Fast Moving Consumer Goods · Agricultural Food & other Products · NSE · Updated 15 July 2026

₹160.62 ↓ 31.6% (1Y)

🎯 Key Takeaways

Nath Bio-Genes is in a strategic growth phase, transitioning from a domestically focused seed company to one with emerging international presence and portfolio diversification. Management is targeting 15-20% revenue growth in FY27, driven by cotton volume expansion, international markets like Uzbekistan, and product innovation.
Revenue grew 14.5% QoQ to ₹37 in Q3FY25.
⚠️ Margin pressure from rising finance and marketing costs, with gross margin declining to 56% from 63%, despite revenue growth.

Market Cap

₹306

P/E Ratio

7.6

Div Yield

0.00%

Promoter

0.0%

✨ Ask AI About NATHBIOGEN 📊 Interactive Charts

📖 The Story

Nath Bio-Genes is in a strategic growth phase, transitioning from a domestically focused seed company to one with emerging international presence and portfolio diversification. Management is targeting 15-20% revenue growth in FY27, driven by cotton volume expansion, international markets like Uzbekistan, and product innovation. While profitability has faced pressure from rising costs and taxes, the company maintains stable margins and a disciplined capital structure, positioning it for long-term reinvestment and incremental scale.

📰 What's Happening

In the latest filing on 2026-05-11, Nath Bio-Genes reported FY26 revenue of ₹4,316 million, up 19% YoY, with cotton volume growth of 22% and maize growth of 54%, offsetting a 15% decline in vegetable seeds. The company highlighted international revenue reaching ₹150 crores against a target of ₹1,000 crores, with Uzbekistan contributing ₹15 crores. PAT declined to ₹384 million due to higher finance and marketing costs, and the effective tax rate rose to 11%. Management emphasized R&D, supply chain strength, and inventory adjustments to support future production stability and margin expansion.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Q4FY23	Q1FY24	Q2FY24	Q3FY24	Q4FY24	Q1FY25	Q2FY25	Q3FY25
Revenue	45	235	23	32	43	244	32	37
Operating Profit	4	37	6	8	5	37	5	9
OPM %	8.7%	15.6%	24.5%	17.8%	9.1%	15.0%	15.0%	21.8%
Net Profit	1	33	2	4	3	33	1	3
EPS	₹0.76	₹17.47	₹0.86	₹2.02	₹1.87	₹17.49	₹0.53	₹1.33

Revenue growth has shown volatility, with Q3FY25 revenue at ₹37 crore, up from ₹244 crore in Q1FY25 but down from the peak of ₹45 crore in Q4FY23, indicating a consolidation phase after earlier spikes. Operating performance remains stable with EBITDA margin holding at 12%, though gross margin declined to 56% from 63% due to input costs and pricing pressures. Despite PAT pressure, the company maintains consistent EPS and margin discipline, with growth increasingly tied to cotton volume gains and international expansion rather than one-off spikes.

🔮 Management Outlook & What's Next

Management has guided FY27 revenue growth of 15-20%, supported by 22% cotton volume growth and continued international market penetration. They emphasized expanding international revenue to 10-15% of total, targeting ₹1,000 crores in top-line expansion. Cotton realization improved from ₹275 to ₹293, and R&D and supply chain investments are being prioritized to sustain growth. Inventory management strategies are being refined to support production stability, with no major M&A or structural shifts announced but a clear focus on portfolio diversification and export-led growth.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Agricultural Food & other Products

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
TATA CONSUMER PRODUCTS LIMITED	1.22 L Cr	83.2	9.4%	7.3%	0.09
Marico Limited	1.09 L Cr	67.8	—	—	—
Patanjali Foods Limited	50,036	30.3	—	—	—
AWL Agri Business Limited	25,958	21.8	—	—	—
CCL Products (India) Limited	14,906	54.3	—	—	—
LT Foods Limited	14,215	23.9	—	—	—
Balrampur Chini Mills Limited	10,897	26.5	—	—	—
Triveni Engineering & Industries Limited	8,190	38.6	—	—	—
KRBL Limited	7,756	17.8	—	—	—
Gujarat Ambuja Exports Limited	7,467	24.2	—	—	—

🔗 Peer Stock Analyses

TATACONSUM MARICO PATANJALI AWL CCL

⚠️ Risk Factors

1. Margin pressure from rising finance and marketing costs, with gross margin declining to 56% from 63%, despite revenue growth. 2. Rising effective tax rate to 11% due to increased marketing expenses, which could impact net profitability. 3. Dependence on cotton volume growth and price realization, which remain volatile due to agro-commodity market swings. 4. Delays or failures in recovering doubtful farmer advances and confirming trade receivables, which could affect working capital and cash flow stability.

📋 Recent Filings

🧠 Analyst's Read

Nath Bio-Genes is executing a clear growth strategy anchored in cotton volume expansion, international markets, and product diversification, but profitability remains sensitive to cost and tax pressures. The company shows resilience in operational metrics and governance, but execution risks in margin recovery and working capital management require close monitoring. Investors should watch for progress toward the ₹1,000 crore revenue target and clarity on international contribution in the next few quarters.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on NATHBIOGEN

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-15.

📡 Get AI alerts when NATHBIOGEN files new disclosures

Track NATHBIOGEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NATHBIOGEN — Free

Free account · 2 AI queries/day